Nexletol
Chemical Name | bempedoic acid |
Dosage Form | Tablet (oral; 180 mg) |
Drug Class | Inhibitors |
System | Cardiovascular |
Company | Esperion |
Approval Year | 2020 |
Indication
- Nexletol is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of LDL-C.